Eur Respir J 2005; 26:390-397
Copyright ©ERS Journals Ltd 2005
Skeletal muscle inflammation and nitric oxide in patients with COPD
M. Montes de Oca1,
S. H. Torres2,
J. De Sanctis3,
A. Mata1,
N. Hernández2 and
C. Tálamo1
1 Pulmonary Division, Hospital Universitario de Caracas, 2 Instituto de Medicina Experimental, Sección de Adaptación Muscular, and 3 Instituto de Inmunología, Universidad Central de Venezuela, Caracas, Venezuela.
CORRESPONDENCE: M. Montes de Oca, Hospital Universitario de Caracas, Piso 8 Servicio de Neumonología, Ciudad Universitaria, Caracas, Venezuela. Fax: 58 2127307503. E-mail: mmdeoca@cantv.net
Keywords: Chronic obstructive pulmonary disease, emphysema, skeletal muscle
Received: September 15, 2004
Accepted April 19, 2005
In chronic obstructive pulmonary disease (COPD) the presence of systemic inflammation has been associated with peripheral muscle abnormalities and weight loss.
To study whether inflammatory factors are important in these processes, the present study compared the skeletal muscle levels of nitrite, nitrate, nitrotyrosine, neuronal, endothelial and inducible nitric oxide synthases (nNOS, eNOS, and iNOS, respectively), and inflammatory markers (tumour necrosis factor (TNF)- , CD154 and CD163) in 15 patients (forced expiratory volume in one second 43±11%) and 14 controls. All these markers were also compared between patients with normal and low body weight.
Nitrite (12.5±2.6 versus 17.0±3.4 µmol·mg1 protein), nitrate (20.7±2.4 versus 24.4±4.5 µmol·mg1 protein) and eNOS (31.9±4.6 versus 43.6±7.5 ng·mg1 protein) were lower in COPD patients than in controls. Nitrotyrosine (25.6±5.4 versus 6.6±3.3 ng·mg1 protein), iNOS expression (32±9.5 versus 7.16±2.7 ng·mg1 protein), TNF- (257±160 versus 48.3±4.4 pg·mg1 protein) and CD163 (6.4±2.1 versus 0.8±0.4 ng·mg1 protein) were higher in COPD patients than in controls. CD154 levels were 15.7±7.0 ng·mg1 protein in COPD patients and undetectable in controls. Similar levels of all these markers were observed in COPD patients with normal and low body weight.
In conclusion, these findings suggest the presence of an inflammatory process in the muscle tissue of chronic obstructive pulmonary disease patients, and argue in favour of its participation in the pathogenesis of skeletal muscle abnormalities.
This article has been cited by other articles:

|
 |

|
 |
 
E Barreiro, R Rabinovich, J Marin-Corral, J A Barbera, J Gea, and J Roca
Chronic endurance exercise induces quadriceps nitrosative stress in patients with severe COPD
Thorax,
January 1, 2009;
64(1):
13 - 19.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. H. Remels, H. R. Gosker, P. Schrauwen, R. C. Langen, and A. M. Schols
Peroxisome proliferator-activated receptors: a therapeutic target in COPD?
Eur. Respir. J.,
March 1, 2008;
31(3):
502 - 508.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. D Sin and W D. Reid
Is inflammation good, bad or irrelevant for skeletal muscles in COPD?
Thorax,
February 1, 2008;
63(2):
95 - 96.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E Barreiro, A M W J Schols, M I Polkey, J B Galdiz, H R Gosker, E B Swallow, C Coronell, J Gea, and on behalf of the ENIGMA in COPD project
Cytokine profile in quadriceps muscles of patients with severe COPD
Thorax,
February 1, 2008;
63(2):
100 - 107.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Montes de Oca, E. Loeb, S. H. Torres, J. De Sanctis, N. Hernandez, and C. Talamo
Peripheral Muscle Alterations in Non-COPD Smokers
Chest,
January 1, 2008;
133(1):
13 - 18.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Vogiatzis, G. Stratakos, D. C M Simoes, G. Terzis, O. Georgiadou, C. Roussos, and S. Zakynthinos
Effects of rehabilitative exercise on peripheral muscle TNF{alpha}, IL-6, IGF-I and MyoD expression in patients with COPD
Thorax,
November 1, 2007;
62(11):
950 - 956.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. C. J. Langen and A. M. W. J. Schols
Inflammation: friend or foe of muscle remodelling in COPD?
Eur. Respir. J.,
October 1, 2007;
30(4):
605 - 607.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Doucet, A. P. Russell, B. Leger, R. Debigare, D. R. Joanisse, M.-A. Caron, P. LeBlanc, and F. Maltais
Muscle Atrophy and Hypertrophy Signaling in Patients with Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med.,
August 1, 2007;
176(3):
261 - 269.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Casanova, C. G. Cote, J. M. Marin, J. P. de Torres, A. Aguirre-Jaime, R. Mendez, L. Dordelly, and B. R. Celli
The 6-min walking distance: long-term follow up in patients with COPD
Eur. Respir. J.,
March 1, 2007;
29(3):
535 - 540.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. A. C. van Helvoort, Y. F. Heijdra, R. C. C. de Boer, A. Swinkels, H. M. H. Thijs, and P. N. R. Dekhuijzen
Six-Minute Walking-Induced Systemic Inflammation and Oxidative Stress in Muscle-Wasted COPD Patients
Chest,
February 1, 2007;
131(2):
439 - 445.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2005 by the European Respiratory Society.
|